# Heparin Sodium

NDC: 0409-1316
Generic name: HEPARIN SODIUM
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20050331

FDA application: ANDA089522

## Active ingredients

- HEPARIN SODIUM: 10000 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-1316"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-1316
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8c4edd2-ee9e-4558-6b8c-b83adc242a0a